NO2451435T3 - - Google Patents
Info
- Publication number
- NO2451435T3 NO2451435T3 NO10797770A NO10797770A NO2451435T3 NO 2451435 T3 NO2451435 T3 NO 2451435T3 NO 10797770 A NO10797770 A NO 10797770A NO 10797770 A NO10797770 A NO 10797770A NO 2451435 T3 NO2451435 T3 NO 2451435T3
- Authority
- NO
- Norway
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B17/00—Sulfur; Compounds thereof
- C01B17/64—Thiosulfates; Dithionites; Polythionates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/22—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2006/00—Physical properties of inorganic compounds
- C01P2006/80—Compositional purity
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/23—Carbon containing
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Virology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22399309P | 2009-07-08 | 2009-07-08 | |
| PCT/US2010/041182 WO2011005841A1 (en) | 2009-07-08 | 2010-07-07 | Sodium thiosulfate-containing pharmaceutical compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO2451435T3 true NO2451435T3 (it) | 2018-03-31 |
Family
ID=43427659
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO10797770A NO2451435T3 (it) | 2009-07-08 | 2010-07-07 |
Country Status (12)
| Country | Link |
|---|---|
| US (14) | US8496973B2 (it) |
| EP (2) | EP3213756A1 (it) |
| JP (9) | JP5905387B2 (it) |
| AU (1) | AU2010270605B2 (it) |
| CA (1) | CA2767168C (it) |
| DK (1) | DK2451435T4 (it) |
| ES (1) | ES2655883T5 (it) |
| HU (1) | HUE035519T2 (it) |
| NO (1) | NO2451435T3 (it) |
| PL (1) | PL2451435T5 (it) |
| PT (1) | PT2451435T (it) |
| WO (1) | WO2011005841A1 (it) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8568793B2 (en) | 2009-02-11 | 2013-10-29 | Hope Medical Enterprises, Inc. | Sodium nitrite-containing pharmaceutical compositions |
| NO2451435T3 (it) | 2009-07-08 | 2018-03-31 | ||
| CA2860835A1 (en) * | 2012-01-09 | 2013-07-18 | General Electric Company | Methods of stabilizing total organic carbon (toc) levels in non-acidified standards for toc analyzers at room temperature |
| US9629872B2 (en) | 2012-05-10 | 2017-04-25 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Sodium thiosulphate for the treatment of ectopic calcifications |
| FR2992861B1 (fr) * | 2012-07-09 | 2014-10-17 | Probionov | Utilisation de thiosulfate pour potentialiser l'effet anti-pathogene des lactobacilles |
| JP2016508996A (ja) * | 2013-01-28 | 2016-03-24 | ヌエヴァス オルタナティヴァス ナチュラルズ，エス．エー．ピー．アイ．デ シー．ブイ． | 酸化ストレス及び／又は酸化還元不均衡の結果生じる病的状態の全身的治療のための組成物 |
| WO2014165057A1 (en) * | 2013-03-12 | 2014-10-09 | Sichtnik Laszlo | Compositions and methods for treating infectious disease |
| CN104749304A (zh) * | 2013-12-26 | 2015-07-01 | 上海宝钢化工有限公司 | 一种测定脱硫溶液中氰离子与硫离子浓度的方法 |
| US9539305B1 (en) * | 2014-03-14 | 2017-01-10 | Fleurir Abx Llc | Pristinamycin compositions, LpxC compositions, their improvements, and combinations thereof |
| CN104071759B (zh) * | 2014-06-13 | 2016-07-06 | 安徽佑骏商品混凝土有限公司 | 一种硫代硫酸钠的制备方法 |
| US20190269721A1 (en) * | 2016-11-04 | 2019-09-05 | Merz North America, Inc. | Methods and compositions for degrading calcium phosphate and for treating calcification disorders |
| WO2018165108A1 (en) | 2017-03-08 | 2018-09-13 | Hope Medical Enterprises, Inc. Dba Hope Pharmaceuticals | Intradialytic use of sodium thiosulfate |
| EP3592342B1 (en) | 2017-03-08 | 2024-06-19 | Hope Medical Enterprises, Inc. d.b.a. Hope Pharmaceuticals | Intradialytic use of sodium nitrite |
| US10596190B2 (en) | 2017-11-29 | 2020-03-24 | Oregon Health & Science University | Method for reducing ototoxicity in pediatric patients receiving platinum-based chemotherapy |
| AU2019218232A1 (en) * | 2018-02-09 | 2020-09-24 | Decibel Therapeutics, Inc. | Hypertonic pharmaceutical compositions containing an anti-platinum chemoprotectant agent |
| WO2019222856A1 (en) | 2018-05-24 | 2019-11-28 | Nureva Inc. | Method, apparatus and computer-readable media to manage semi-constant (persistent) sound sources in microphone pickup/focus zones |
| EP3801378A4 (en) | 2018-05-24 | 2022-02-23 | Celanese EVA Performance Polymers LLC | IMPLANTABLE DEVICE FOR THE DELAYED RELEASE OF A MACROMOLECULAR DRUG COMPOUND |
| KR20210013088A (ko) | 2018-05-24 | 2021-02-03 | 셀라니즈 이브이에이 퍼포먼스 폴리머스 엘엘씨 | 거대 분자 약물 화합물의 지속적인 방출을 위한 이식가능 장치 |
| MX2020013733A (es) | 2018-07-03 | 2021-05-27 | Fennec Pharmaceuticals Inc | Tiosulfato de sodio anhidro y formulaciones de este. |
| CN109678598B (zh) * | 2018-09-29 | 2021-05-18 | 江西省农业科学院土壤肥料与资源环境研究所 | 一种土壤修复肥料及其制备方法 |
| US11166981B2 (en) * | 2019-04-03 | 2021-11-09 | National Jewish Health | Methods and compositions for treating chlorine-gas induced lung injury |
| CN110146605A (zh) * | 2019-04-19 | 2019-08-20 | 南通联亚药业有限公司 | 一种测定格列吡嗪原料药及其缓释片中特定基因毒性杂质的分析方法 |
| US10813947B1 (en) | 2019-05-31 | 2020-10-27 | Decibel Therapeutics, Inc. | Methods of otoprotection against platinum-based antineoplastic agents |
| WO2020243536A1 (en) * | 2019-05-31 | 2020-12-03 | Decibel Therapeutics, Inc. | Methods of otoprotection against platinum-based antineoplastic agents |
| FR3099051A1 (fr) * | 2019-07-25 | 2021-01-29 | Laboratoires Grimberg | Composition pour pulvérisation nasale ou buccale contenant du soufre |
| CN110426473B (zh) * | 2019-08-09 | 2022-03-15 | 广西壮族自治区亚热带作物研究所（广西亚热带农产品加工研究所） | 一种同时测定酱腌菜中三种防腐剂的方法 |
| US11452690B1 (en) | 2021-01-27 | 2022-09-27 | ECI Pharmaceuticals, LLC | Oral liquid compositions comprising amlodipine besylate and methods of using the same |
| US20220288110A1 (en) * | 2021-02-22 | 2022-09-15 | Arterez, Inc. | Drug treatment and biomarker panel targeted to diseases due to multifactorial ontology of glycocalyx disruption |
| EP4212149A1 (en) | 2022-01-18 | 2023-07-19 | Rijksuniversiteit Groningen | Oral dosage forms of acid-labile salt and methods and uses related thereto |
| CN115444857B (zh) * | 2022-08-30 | 2023-08-01 | 安徽丰原药业股份有限公司 | 一种氰化物解毒剂注射液的制备方法 |
| WO2024092228A2 (en) * | 2022-10-28 | 2024-05-02 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Localized delivery of sodium thiosulfate nanoparticles to mitigate arterial calcification |
| CN116062708B (zh) * | 2022-12-02 | 2024-09-17 | 东南大学 | 一种硫代硫酸钠的合成方法 |
| US20240277758A1 (en) * | 2022-12-28 | 2024-08-22 | Hope Medical Enterprises, Inc. Dba Hope Pharmaceuticals | Use of sodium thiosulfate for the treatment of sulfur mustard exposure |
Family Cites Families (110)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1488829A (en) * | 1923-04-18 | 1924-04-01 | Jessup & Mnoore Paper Co | Process of making cooking liquors |
| US2032699A (en) * | 1932-07-23 | 1936-03-03 | Solvay Process Co | Process for the production of sodium nitrite |
| US2023699A (en) | 1934-06-11 | 1935-12-10 | Albert P Robinson | Vehicle ventilating means |
| GB500489A (en) | 1936-08-07 | 1939-02-09 | Ig Farbenindustrie Ag | Improvements in or relating to the manufacture of water-soluble hyposulphites |
| US2475616A (en) * | 1945-02-09 | 1949-07-12 | Harold E Ingraham | Thiosulfate salts |
| US2763531A (en) * | 1952-11-29 | 1956-09-18 | Eastman Kodak Co | Manufacture of sodium thiosulphate from sodium sulfite and sulfur in presence of cationic surface active organic bromides |
| NL203871A (it) | 1955-02-09 | 1900-01-01 | ||
| US2933377A (en) * | 1956-08-01 | 1960-04-19 | Du Pont | Process for making non-caking and free-flowing sodium nitrite |
| US3536809A (en) | 1969-02-17 | 1970-10-27 | Alza Corp | Medication method |
| US3598123A (en) | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
| JPS4838557B1 (it) * | 1970-12-24 | 1973-11-17 | ||
| JPS4733199U (it) | 1971-05-15 | 1972-12-13 | ||
| JPS4838557A (it) | 1971-09-22 | 1973-06-06 | ||
| US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
| US3916899A (en) | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
| JPS5131115B2 (it) * | 1973-06-05 | 1976-09-04 | ||
| US4162187A (en) * | 1974-05-09 | 1979-07-24 | The Mead Corporation | Process for production of sodium thiosulfate and sodium hydroxide |
| US3965247A (en) * | 1975-06-20 | 1976-06-22 | Allied Chemical Corporation | Recovery of sodium nitrite from by-product process liquors containing sodium chloride |
| US4008719A (en) | 1976-02-02 | 1977-02-22 | Alza Corporation | Osmotic system having laminar arrangement for programming delivery of active agent |
| US4105754A (en) * | 1977-10-25 | 1978-08-08 | Allied Chemical Corporation | Production of high purity calcium thiosulfate |
| US4543190A (en) | 1980-05-08 | 1985-09-24 | Modar, Inc. | Processing methods for the oxidation of organics in supercritical water |
| US4292311A (en) | 1980-12-23 | 1981-09-29 | Sarnoff Stanley J | Cyanide antidote |
| US4410545A (en) | 1981-02-13 | 1983-10-18 | Syntex (U.S.A.) Inc. | Carbonate diester solutions of PGE-type compounds |
| US4328245A (en) | 1981-02-13 | 1982-05-04 | Syntex (U.S.A.) Inc. | Carbonate diester solutions of PGE-type compounds |
| US4409239A (en) | 1982-01-21 | 1983-10-11 | Syntex (U.S.A.) Inc. | Propylene glycol diester solutions of PGE-type compounds |
| ES8702440A1 (es) | 1984-10-04 | 1986-12-16 | Monsanto Co | Un procedimiento para la preparacion de una composicion de polipeptido inyectable sustancialmente no acuosa. |
| IE58110B1 (en) | 1984-10-30 | 1993-07-14 | Elan Corp Plc | Controlled release powder and process for its preparation |
| US4590183A (en) * | 1985-04-22 | 1986-05-20 | Sterling Drug Inc. | Gastric cytoprotection with sodium thiosulfate in oral administration of aspirin |
| US5033252A (en) | 1987-12-23 | 1991-07-23 | Entravision, Inc. | Method of packaging and sterilizing a pharmaceutical product |
| US5052558A (en) | 1987-12-23 | 1991-10-01 | Entravision, Inc. | Packaged pharmaceutical product |
| US5073543A (en) | 1988-07-21 | 1991-12-17 | G. D. Searle & Co. | Controlled release formulations of trophic factors in ganglioside-lipsome vehicle |
| US5612059A (en) | 1988-08-30 | 1997-03-18 | Pfizer Inc. | Use of asymmetric membranes in delivery devices |
| IT1229203B (it) | 1989-03-22 | 1991-07-25 | Bioresearch Spa | Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative. |
| PH30995A (en) | 1989-07-07 | 1997-12-23 | Novartis Inc | Sustained release formulations of water soluble peptides. |
| US5120548A (en) | 1989-11-07 | 1992-06-09 | Merck & Co., Inc. | Swelling modulated polymeric drug delivery device |
| US5585112A (en) | 1989-12-22 | 1996-12-17 | Imarx Pharmaceutical Corp. | Method of preparing gas and gaseous precursor-filled microspheres |
| IT1246382B (it) | 1990-04-17 | 1994-11-18 | Eurand Int | Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon |
| US5733566A (en) | 1990-05-15 | 1998-03-31 | Alkermes Controlled Therapeutics Inc. Ii | Controlled release of antiparasitic agents in animals |
| US5543390A (en) | 1990-11-01 | 1996-08-06 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University | Covalent microparticle-drug conjugates for biological targeting |
| USH1126H (en) | 1991-11-12 | 1993-01-05 | The United States Of America As Represented By The Secretary Of The Navy | Treatment of sodium nitrite-containing boiler wastewater |
| US5580578A (en) | 1992-01-27 | 1996-12-03 | Euro-Celtique, S.A. | Controlled release formulations coated with aqueous dispersions of acrylic polymers |
| JPH05286712A (ja) * | 1992-04-08 | 1993-11-02 | Asahi Chem Ind Co Ltd | 硫化アルカリ含有溶液の酸化方法 |
| US5323907A (en) | 1992-06-23 | 1994-06-28 | Multi-Comp, Inc. | Child resistant package assembly for dispensing pharmaceutical medications |
| TW333456B (en) | 1992-12-07 | 1998-06-11 | Takeda Pharm Ind Co Ltd | A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide. |
| US5591767A (en) | 1993-01-25 | 1997-01-07 | Pharmetrix Corporation | Liquid reservoir transdermal patch for the administration of ketorolac |
| US6274552B1 (en) | 1993-03-18 | 2001-08-14 | Cytimmune Sciences, Inc. | Composition and method for delivery of biologically-active factors |
| US5405533A (en) | 1993-04-07 | 1995-04-11 | General Atomics | Heat transfer via dense gas in a fluid circulation system |
| US5523092A (en) | 1993-04-14 | 1996-06-04 | Emory University | Device for local drug delivery and methods for using the same |
| US5985307A (en) | 1993-04-14 | 1999-11-16 | Emory University | Device and method for non-occlusive localized drug delivery |
| US6087324A (en) | 1993-06-24 | 2000-07-11 | Takeda Chemical Industries, Ltd. | Sustained-release preparation |
| US6004534A (en) | 1993-07-23 | 1999-12-21 | Massachusetts Institute Of Technology | Targeted polymerized liposomes for improved drug delivery |
| US5387398A (en) | 1993-12-03 | 1995-02-07 | Aerojet General Corporation | Supercritical water oxidation reactor with wall conduits for boundary flow control |
| US6056883A (en) | 1994-06-07 | 2000-05-02 | Abitibi Consolidated Inc. | Method and apparatus to remove inorganic scale from a supercritical water oxidation reactor |
| US5501799A (en) | 1994-06-07 | 1996-03-26 | Abitibi-Price, Inc. | Method to remove inorganic scale from a supercritical water oxidation reactor |
| IT1270594B (it) | 1994-07-07 | 1997-05-07 | Recordati Chem Pharm | Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida |
| US6290991B1 (en) * | 1994-12-02 | 2001-09-18 | Quandrant Holdings Cambridge Limited | Solid dose delivery vehicle and methods of making same |
| US5759542A (en) | 1994-08-05 | 1998-06-02 | New England Deaconess Hospital Corporation | Compositions and methods for the delivery of drugs by platelets for the treatment of cardiovascular and other diseases |
| US5660854A (en) | 1994-11-28 | 1997-08-26 | Haynes; Duncan H | Drug releasing surgical implant or dressing material |
| US6316652B1 (en) | 1995-06-06 | 2001-11-13 | Kosta Steliou | Drug mitochondrial targeting agents |
| US5798119A (en) | 1995-06-13 | 1998-08-25 | S. C. Johnson & Son, Inc. | Osmotic-delivery devices having vapor-permeable coatings |
| EP0835101B1 (en) | 1995-06-27 | 2004-06-09 | Takeda Chemical Industries, Ltd. | Method of producing sustained-release preparation |
| TW448055B (en) | 1995-09-04 | 2001-08-01 | Takeda Chemical Industries Ltd | Method of production of sustained-release preparation |
| JP2909418B2 (ja) | 1995-09-18 | 1999-06-23 | 株式会社資生堂 | 薬物の遅延放出型マイクロスフイア |
| US6039975A (en) | 1995-10-17 | 2000-03-21 | Hoffman-La Roche Inc. | Colon targeted delivery system |
| US5980945A (en) | 1996-01-16 | 1999-11-09 | Societe De Conseils De Recherches Et D'applications Scientifique S.A. | Sustained release drug formulations |
| US5804066A (en) | 1996-02-08 | 1998-09-08 | Aerojet-General Corporation | Injector for SCWO reactor |
| TW345603B (en) | 1996-05-29 | 1998-11-21 | Gmundner Fertigteile Gmbh | A noise control device for tracks |
| US6264970B1 (en) | 1996-06-26 | 2001-07-24 | Takeda Chemical Industries, Ltd. | Sustained-release preparation |
| US6419961B1 (en) | 1996-08-29 | 2002-07-16 | Takeda Chemical Industries, Ltd. | Sustained release microcapsules of a bioactive substance and a biodegradable polymer |
| IL129242A0 (en) | 1996-10-01 | 2000-02-17 | Cima Labs Inc | Taste-masked microcapsule compositions and methods of manufacture |
| CA2217134A1 (en) | 1996-10-09 | 1998-04-09 | Sumitomo Pharmaceuticals Co., Ltd. | Sustained release formulation |
| PT839525E (pt) | 1996-10-31 | 2004-10-29 | Takeda Chemical Industries Ltd | Preparacao de libertacao prolongada |
| WO1998022817A1 (en) † | 1996-11-18 | 1998-05-28 | Tekmar Company | Liquid sample carbon analyzer |
| US6131570A (en) | 1998-06-30 | 2000-10-17 | Aradigm Corporation | Temperature controlling device for aerosol drug delivery |
| ZA9711385B (en) | 1996-12-20 | 1999-06-18 | Takeda Chemical Industries Ltd | Method of producing a sustained-release preparation |
| US5891474A (en) | 1997-01-29 | 1999-04-06 | Poli Industria Chimica, S.P.A. | Time-specific controlled release dosage formulations and method of preparing same |
| US6120751A (en) | 1997-03-21 | 2000-09-19 | Imarx Pharmaceutical Corp. | Charged lipids and uses for the same |
| US6060082A (en) | 1997-04-18 | 2000-05-09 | Massachusetts Institute Of Technology | Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery |
| US6054057A (en) | 1997-09-26 | 2000-04-25 | General Atomics | Downflow hydrothermal treatment |
| US6350458B1 (en) | 1998-02-10 | 2002-02-26 | Generex Pharmaceuticals Incorporated | Mixed micellar drug deliver system and method of preparation |
| US6613358B2 (en) | 1998-03-18 | 2003-09-02 | Theodore W. Randolph | Sustained-release composition including amorphous polymer |
| US6048736A (en) | 1998-04-29 | 2000-04-11 | Kosak; Kenneth M. | Cyclodextrin polymers for carrying and releasing drugs |
| KR19990085365A (ko) | 1998-05-16 | 1999-12-06 | 허영섭 | 지속적으로 약물 조절방출이 가능한 생분해성 고분자 미립구 및그 제조방법 |
| US6248363B1 (en) | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| US6251354B1 (en) * | 1999-04-02 | 2001-06-26 | General Electric Co. | Process for recovering sodium nitrite |
| US6271359B1 (en) | 1999-04-14 | 2001-08-07 | Musc Foundation For Research Development | Tissue-specific and pathogen-specific toxic agents and ribozymes |
| US6238568B1 (en) | 1999-05-06 | 2001-05-29 | General Atomics | Hydrothermal processing with phosphate additive |
| DE60118172T2 (de) | 2000-04-26 | 2007-03-08 | Oregon Health Sciences University, Portland | Verabreichung von einer chemoschützenden verbindung,welche eine thiolgruppe enthält |
| EP1313473A2 (en) | 2000-08-30 | 2003-05-28 | Pfizer Products Inc. | Sustained release formulations for growth hormone secretagogues |
| KR100331952B1 (ko) | 2000-11-23 | 2002-04-09 | 최수일 | 다목적 고기능성 알칼리 용액 조성물 및 그 제조방법과 비특이 면역증강제로서의 용도 |
| US6576185B2 (en) | 2000-12-28 | 2003-06-10 | General Atomics | System and method for hydrothermal reactions-three layer liner |
| US6709602B2 (en) | 2001-04-23 | 2004-03-23 | General Atomics | Process for hydrothermal treatment of materials |
| US6519926B2 (en) | 2001-05-01 | 2003-02-18 | General Atomics | Hydrothermal conversion and separation |
| JP4863589B2 (ja) * | 2001-09-28 | 2012-01-25 | ロート製薬株式会社 | 水性組成物 |
| US6773581B2 (en) | 2001-10-18 | 2004-08-10 | General Atomics | System and method for solids transport in hydrothermal processes |
| US20030235571A1 (en) * | 2002-06-19 | 2003-12-25 | Gabriel Gojon-Romanillos | Systemic treatment of pathological conditions resulting from oxidative stress and/or redox imbalance |
| US6855306B2 (en) * | 2002-09-26 | 2005-02-15 | General Chemical Performance Products Llc | Process for the recovery of sodium nitrite |
| AU2003304398A1 (en) * | 2002-10-16 | 2005-02-25 | Board Of Regents, The University Of Texas System | Methods and compositions for increasing the efficacy of biologically-active ingredients |
| US8093423B2 (en) | 2003-02-19 | 2012-01-10 | Globoasia, Llc | Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same |
| AU2004255268B2 (en) | 2003-07-09 | 2010-04-01 | Loma Linda University | Use of nitrite salts for the treatment of cardiovascular conditions |
| US20080069779A1 (en) * | 2003-08-04 | 2008-03-20 | Foamix Ltd. | Foamable vehicle and vitamin and flavonoid pharmaceutical compositions thereof |
| US7312243B1 (en) * | 2003-08-29 | 2007-12-25 | Jay Pravda | Materials and methods for treatment of gastrointestinal disorders |
| WO2005056102A1 (en) * | 2003-12-15 | 2005-06-23 | Nitricare Kb | Device and method for administering therapeutic agents |
| JP4315831B2 (ja) | 2004-02-17 | 2009-08-19 | 株式会社マンダム | 防腐殺菌剤並びに該防腐殺菌剤を配合した化粧料、医薬品及び食品 |
| JP2006143590A (ja) * | 2004-10-21 | 2006-06-08 | Rohto Pharmaceut Co Ltd | 粘膜適用組成物 |
| JP4838557B2 (ja) | 2005-09-12 | 2011-12-14 | キヤノン株式会社 | ズームレンズ及びそれを有する撮像装置 |
| RU2372923C2 (ru) * | 2007-08-27 | 2009-11-20 | Государственное учреждение Научно-исследовательский институт экспериментальной медицины Российской Академии медицинских наук (ГУ НИИЭМ РАМН) | Средство, обладающее гиполипидемической и антиатеросклеротической активностью |
| US8568793B2 (en) | 2009-02-11 | 2013-10-29 | Hope Medical Enterprises, Inc. | Sodium nitrite-containing pharmaceutical compositions |
| NO2451435T3 (it) * | 2009-07-08 | 2018-03-31 | ||
| KR101601393B1 (ko) | 2014-02-20 | 2016-03-09 | 현대자동차주식회사 | 차량용 비상 버튼 |
-
2010
- 2010-07-07 NO NO10797770A patent/NO2451435T3/no unknown
- 2010-07-07 PT PT107977704T patent/PT2451435T/pt unknown
- 2010-07-07 PL PL10797770T patent/PL2451435T5/pl unknown
- 2010-07-07 US US12/831,331 patent/US8496973B2/en active Active
- 2010-07-07 EP EP17165738.0A patent/EP3213756A1/en active Pending
- 2010-07-07 JP JP2012519695A patent/JP5905387B2/ja not_active Ceased
- 2010-07-07 ES ES10797770T patent/ES2655883T5/es active Active
- 2010-07-07 WO PCT/US2010/041182 patent/WO2011005841A1/en active Application Filing
- 2010-07-07 EP EP10797770.4A patent/EP2451435B2/en active Active
- 2010-07-07 CA CA2767168A patent/CA2767168C/en active Active
- 2010-07-07 AU AU2010270605A patent/AU2010270605B2/en active Active
- 2010-07-07 DK DK10797770.4T patent/DK2451435T4/da active
- 2010-07-07 HU HUE10797770A patent/HUE035519T2/en unknown
-
2013
- 2013-06-26 US US13/927,241 patent/US8715746B2/en active Active
-
2014
- 2014-03-24 US US14/222,766 patent/US9144580B2/en active Active
- 2014-06-20 US US14/310,133 patent/US9345724B2/en active Active
-
2016
- 2016-01-15 JP JP2016006438A patent/JP6166393B2/ja active Active
- 2016-01-15 JP JP2016006439A patent/JP6182622B2/ja active Active
- 2016-04-25 US US15/137,082 patent/US9579345B2/en active Active
- 2016-08-31 US US15/252,324 patent/US9585912B2/en active Active
-
2017
- 2017-01-19 US US15/409,659 patent/US9944524B2/en active Active
- 2017-05-08 JP JP2017092471A patent/JP6438071B2/ja active Active
-
2018
- 2018-03-09 US US15/916,950 patent/US10479686B2/en active Active
- 2018-11-15 JP JP2018214592A patent/JP6598965B2/ja active Active
- 2018-12-04 US US16/208,667 patent/US10479687B2/en active Active
-
2019
- 2019-01-15 US US16/248,026 patent/US10723623B2/en active Active
- 2019-10-01 JP JP2019181475A patent/JP6852136B2/ja active Active
-
2020
- 2020-06-19 US US16/905,959 patent/US11142456B2/en active Active
-
2021
- 2021-03-10 JP JP2021038213A patent/JP7166377B2/ja active Active
- 2021-09-08 US US17/469,006 patent/US11753300B2/en active Active
-
2022
- 2022-10-25 JP JP2022170542A patent/JP7408753B2/ja active Active
-
2023
- 2023-02-13 US US18/108,803 patent/US11753301B2/en active Active
- 2023-07-25 US US18/225,852 patent/US20240101422A1/en not_active Abandoned
- 2023-12-20 JP JP2023215105A patent/JP2024037998A/ja active Pending